Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Middle East Healthcare CoSAU:4009 +0.60%79 Pretax Margin % is 3.92% as of Mar. 2026, which is 56% below its 10-year median of 8.85. GuruFocus rates SAU:4009 with a GF Score™ of 79/100 and a GF Value™ of ﷼80.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Middle East Healthcare Co ranks better than 58.46% on this metric.
The historical rank and industry rank for Middle East Healthcare Co's Pretax Margin % or its related term are showing as below:
SAU:4009'
s Pretax Margin % Range Over the Past 10 Years
Min: 1.03 Med: 8.85 Max: 22.5
Current: 5.98
SAU:4009's Pretax Margin % is ranked better than 58.46% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 4.05
vs SAU:4009: 5.98
Middle East Healthcare Co (SAU:4009) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Middle East Healthcare Co Pretax Margin % Related Terms
Middle East Healthcare Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4009 vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Middle East Healthcare Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Healthcare Co Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Middle East Healthcare Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Healthcare Co (SAU:4009) has a Pretax Margin % of 3.92% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Middle East Healthcare Co and its competitors. This is 56% below median its historical median of 8.85. Over the past decade, Middle East Healthcare Co's Pretax Margin % has ranged from 1.03 to 22.50. According to the industry distribution chart, Middle East Healthcare Co ranks #275 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 41.5%.
Is Middle East Healthcare Co's Pretax Margin % too high?
Middle East Healthcare Co's current Pretax Margin % of 3.92% is 56% below median its 10-year median of 8.85. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 22.50. The Healthcare Providers & Services industry median Pretax Margin % is 4.05. Middle East Healthcare Co's value of 3.92% is 3.2% below this industry median. Based on the distribution chart, Middle East Healthcare Co ranks #275 out of 662 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Middle East Healthcare Co has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Middle East Healthcare Co ranks #275 out of 662 companies for Pretax Margin %. This puts Middle East Healthcare Co in the upper half of its industry. The industry median Pretax Margin % is 4.05. Middle East Healthcare Co's value of 3.92% is 3.2% below this benchmark. Historically, Middle East Healthcare Co's own Pretax Margin % has ranged from 1.03 to 22.50 over the past decade. While the company's 10-year median is 8.85 vs. the industry median of 4.05, Middle East Healthcare Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.05, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Healthcare Co's current Pretax Margin % of 3.92% is 3.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Middle East Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Healthcare Co's current Pretax Margin % is 3.92%, which is 56% below median its own 10-year median of 8.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼80.23, compared to a current price of ﷼30.28 — trading 62.3% below its estimated fair value. The current Pretax Margin % is 3.92%, which is 56% below median its 10-year median of 8.85 and 3.2% below the Healthcare Providers & Services industry median of 4.05. Middle East Healthcare Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current Pretax Margin % is 3.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?
Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued.
The current stock price of ﷼30.28 is trading 62.3% below its estimated GF Value™ of ﷼80.23.
GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4009:
Pretax Margin %: 3.92% (56% below median its 10-year median of 8.85)
GF Value™: ﷼80.23 vs. price of ﷼30.28 (62.3% below fair value)
Industry Position: 3.2% below the Healthcare Providers & Services median (#275 of 662)
No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
79GF Score
Get the complete analysis for SAU:4009
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4009 has been successfully added to your 
